Page last updated: 2024-08-24

atorvastatin and Ischemic Attack, Transient

atorvastatin has been researched along with Ischemic Attack, Transient in 44 studies

Research

Studies (44)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	24 (54.55)	29.6817
2010's	17 (38.64)	24.3611
2020's	3 (6.82)	2.80

Authors

Authors	Studies
Amarenco, P; Bath, PM; Chen, W; Gao, Y; Han, S; Jing, J; Johnston, SC; Li, H; Liu, L; Meng, X; Pan, Y; Wang, C; Wang, T; Wang, Y; Yang, Y; Zhao, X	1
Amarenco, P; Callahan, A; DeMicco, D; Fayyad, R; Goldstein, LB; Laskey, R; Sillesen, H; Szarek, M; Welch, KM	1
Amarenco, P; Callahan, A; Goldstein, LB; Sillesen, H; Szarek, M; Welch, KM	1
Amarenco, P; Callahan, A; Goldstein, LB; Hennerici, MG; Messig, M; Ovbiagele, B; Sillesen, H; Welch, KM; Zivin, J	1
Cao, Z; Feng, Y; Gao, P; Lu, Z; Wang, P; Wang, S; Zhang, G; Zhou, P	1
Amarenco, P; Callahan, A; Campese, VM; Goldstein, LB; Hennerici, MG; Messig, M; Sillesen, H; Welch, KM; Wilson, DJ; Zivin, JA	1
Giacomini, P; Izzo, C; Manuppella, F; Marchione, P; Maugeri, A; Morreale, M; Romeo, T; Vento, C	1
Cheon, SY; Cho, KJ; Kim, GW	1
Acha-Salazar, O; Larrosa-Campo, D; Novo-Robledo, F; Oterino, A; Palacio, E; Revilla, M; Viadero-Cervera, R	1
Bao, W; Byun, YS; DeMicco, D; Laskey, R; Tsimikas, S; Witztum, JL; Yang, X	1
Amarenco, P; Breazna, A; Callahan, A; Chaturvedi, S; Goldstein, LB; Hennerici, M; Rudolph, A; Sillesen, H; Welch, MA; Zivin, J	1
Fitchett, DH; Goodman, SG; Langer, A	1
Amarenco, P; Callahan, A; Goldstein, LB; Hennerici, MG; Messig, M; Sillesen, H; Welch, KM; Zivin, J	1
Amarenco, P; Callahan, A; Goldstein, LB; Hennerici, MG; O'Neill, BJ; Rudolph, AE; Sillesen, H; Simunovic, L; Welch, KM; Zivin, JA	1
Zuber, M	1
Caínzos Romero, T; Fernández Fernández, FJ; Pía Iglesias, G; Sesma, P	1
Hart, RG	1
Amarenco, P; Callahan, A; Goldstein, LB; Hennerici, MG; Messig, M; O'Neill, BJ; Sillesen, H; Welch, KM; Zivin, JA	1
Caro, JJ; Kongnakorn, T; O'Brien, JA; Proskorovsky, I; Roberts, CS; Ward, A	1
Fu, YG; Guo, YD; Tan, ZF; Wang, TG; Xu, AD; Yang, WY	1
Castilla-Guerra, L; Chaturvedi, S; Fernandez-Moreno, Mdel C; Jimenez-Hernandez, MD	1
Chaturvedi, S; Goldstein, MR; Mascitelli, L; Pezzetta, F	1
Landau, W	1
Strupp, M	1
Derksen, C; Khan, K; Saqqur, M; Sebastian, J	1
Amarenco, P; Benavente, O; Callahan, A; Goldstein, LB; Hennerici, MG; Sillesen, H; Welch, KM; Zivin, JA; Zweifler, RM	1
Huisa, BN; Stemer, AB; Zivin, JA	1
Kamran, KA; Khan, M	1
Dougu, N; Nukui, T; Taguchi, Y; Takashima, S; Tanaka, K; Toyoda, S	1
Arrospide, A; Caro, J; Mar, J; Rejas-Gutiérrez, J; Vivancos-Mora, J	1
Charles, J; Miller, G; Pan, Y	1
Chaitman, BR; Goldberger, JJ; Messig, M; Schwartz, GG	1
Altafullah, I; Amarenco, P; Callahan, A; Goldstein, LB; Hennerici, M; Ledbetter, LY; MacLeod, MJ; Messig, M; Samsa, GP; Scott, R; Sillesen, H; Welch, KM; Zivin, JA	1
Ageno, W; Dentali, F; Romualdi, E; Squizzato, A	1
Amarenco, P; Bogousslavsky, J; Callahan, A; Goldstein, LB; Hennerici, M; Rudolph, AE; Sillesen, H; Simunovic, L; Szarek, M; Welch, KM; Zivin, JA	1
Kent, DM	1
Khan, NA	1
Heering, NJ	1
Kulbertus, H	1
Arca, M; Gaspardone, A	1
Amarenco, P	1
Karam, JG; Loney-Hutchinson, L; McFarlane, SI	1

Reviews

4 review(s) available for atorvastatin and Ischemic Attack, Transient

Article	Year
What's new in stroke? The top 10 studies of 2006-2008. Part II. Polskie Archiwum Medycyny Wewnetrznej, 2008, Volume: 118, Issue:12 Topics: Anticoagulants; Atorvastatin; Drug Therapy, Combination; Enoxaparin; Evidence-Based Medicine; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Stroke	2008
Statins for acute ischemic stroke. The Cochrane database of systematic reviews, 2011, Aug-10, Issue:8 Topics: Atorvastatin; Cause of Death; Clopidogrel; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Neuroprotective Agents; Platelet Aggregation Inhibitors; Pyrroles; Randomized Controlled Trials as Topic; Simvastatin; Stroke; Ticlopidine	2011
Atorvastatin: its clinical role in cerebrovascular prevention. Drugs, 2007, Volume: 67 Suppl 1 Topics: Atorvastatin; Cardiovascular Diseases; Coronary Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Pyrroles; Stroke	2007
Atorvastatin in prevention of stroke and transient ischaemic attack. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:16 Topics: Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Pyrroles; Randomized Controlled Trials as Topic; Stroke	2007

Trials

14 trial(s) available for atorvastatin and Ischemic Attack, Transient

Article	Year
Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclero Stroke and vascular neurology, 2023, Volume: 8, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Atorvastatin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Ischemic Stroke; Middle Aged; Platelet Aggregation Inhibitors; Stroke	2023
Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial. Journal of the American College of Cardiology, 2020, 05-05, Volume: 75, Issue:17 Topics: Atorvastatin; Cholesterol, LDL; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Male; Stroke; Treatment Outcome	2020
Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trial. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2014, Volume: 23, Issue:4 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Coronary Disease; Female; Follow-Up Studies; Heptanoic Acids; Humans; Ischemic Attack, Transient; Male; Middle Aged; Prognosis; Pyrroles; Risk Assessment; Stroke; Treatment Outcome; Vascular Diseases	2014
Efficacy and safety of intensive statin therapy in Chinese patients with atherosclerotic intracranial arterial stenosis: a single-center, randomized, single-blind, parallel-group study with one-year follow-up. Clinical neurology and neurosurgery, 2014, Volume: 120 Topics: Aged; Atorvastatin; China; Clinical Protocols; Constriction, Pathologic; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Male; Middle Aged; Middle Cerebral Artery; Pyrroles; Single-Blind Method; Stroke; Vertebrobasilar Insufficiency	2014
Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial. Stroke, 2014, Volume: 45, Issue:10 Topics: Aged; Atorvastatin; Double-Blind Method; Female; Glomerular Filtration Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Kidney; Male; Middle Aged; Pyrroles; Stroke	2014
Atorvastatin treatment and carotid plaque morphology in first-ever atherosclerotic transient ischemic attack/stroke: a case-control study. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2015, Volume: 24, Issue:1 Topics: Aged; Atorvastatin; Carotid Artery Diseases; Case-Control Studies; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Ischemic Attack, Transient; Male; Middle Aged; Plaque, Atherosclerotic; Prospective Studies; Pyrroles; Stroke; Ultrasonography	2015
Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack. Journal of the American College of Cardiology, 2017, Jan-17, Volume: 69, Issue:2 Topics: Aged; Apolipoprotein B-100; Atorvastatin; Biomarkers; Cholesterol, LDL; Coronary Artery Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Phospholipids; Proportional Hazards Models; Recurrence; Secondary Prevention; Stroke	2017
Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis, 2009, Volume: 204, Issue:2 Topics: Aged; Atorvastatin; Blood Pressure; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Male; Middle Aged; Proportional Hazards Models; Pyrroles; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Time Factors; Treatment Outcome; Triglycerides	2009
Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. Stroke, 2009, Volume: 40, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Atorvastatin; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Ischemic Attack, Transient; Male; Middle Aged; Pyrroles; Risk Factors; Secondary Prevention; Stroke; Treatment Outcome; Triglycerides; Young Adult	2009
[The statin dosage for achieving goal of cholesterol-lowering based on risk stratification in patients with ischemic cerebrovascular diseases]. Zhonghua nei ke za zhi, 2009, Volume: 48, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Cystatins; Cysteine Proteinase Inhibitors; Heptanoic Acids; Humans; Ischemic Attack, Transient; Middle Aged; Prospective Studies; Pyrroles; Risk Factors; Treatment Outcome; Young Adult	2009
Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke, 2010, Volume: 41, Issue:3 Topics: Atorvastatin; Cholesterol; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Heptanoic Acids; Humans; Ischemic Attack, Transient; Male; Pyrroles; Stroke	2010
High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. American heart journal, 2011, Volume: 161, Issue:5 Topics: Atorvastatin; Atrial Fibrillation; Cholesterol; Chronic Disease; Disease Progression; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Pyrroles; Retrospective Studies; Stroke; Survival Rate; Time Factors; Treatment Outcome	2011
Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Archives of neurology, 2011, Volume: 68, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Cardiovascular Physiological Phenomena; Cholesterol; Confidence Intervals; Diabetes Mellitus, Type 2; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Lipoproteins, HDL; Lipoproteins, LDL; Male; Metabolic Syndrome; Middle Aged; Proportional Hazards Models; Pyrroles; Retrospective Studies; Risk Factors; Stroke; Triglycerides; Young Adult	2011
High-dose atorvastatin after stroke or transient ischemic attack. The New England journal of medicine, 2006, 08-10, Volume: 355, Issue:6 Topics: Adult; Atorvastatin; Cardiovascular Diseases; Cerebral Hemorrhage; Cerebral Infarction; Cholesterol, LDL; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Male; Proportional Hazards Models; Pyrroles; Risk; Secondary Prevention; Stroke	2006

Other Studies

26 other study(ies) available for atorvastatin and Ischemic Attack, Transient

Article	Year
Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond. Journal of the American College of Cardiology, 2020, 08-18, Volume: 76, Issue:7 Topics: Atorvastatin; Cholesterol, LDL; Hemorrhagic Stroke; Humans; Ischemic Attack, Transient; Stroke	2020
Statins Promote Long-Term Recovery after Ischemic Stroke by Reconnecting Noradrenergic Neuronal Circuitry. Neural plasticity, 2015, Volume: 2015 Topics: Animals; Atorvastatin; Behavior, Animal; Brain Ischemia; Cell Proliferation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Locus Coeruleus; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Neural Pathways; Neurogenesis; Recovery of Function; Stroke; Sympathetic Nervous System	2015
[Utility of treatment with atorvastatin 40 mg plus ezetimibe 10 mg versus atorvastatin 80 mg in reducing the levels of LDL cholesterol in patients with ischaemic stroke or transient ischaemic attack]. Revista de neurologia, 2016, Mar-01, Volume: 62, Issue:5 Topics: Anticholesteremic Agents; Atorvastatin; Brain Ischemia; Cholesterol, LDL; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Male; Middle Aged; Retrospective Studies; Stroke	2016
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology, 2009, Feb-24, Volume: 72, Issue:8 Topics: Age Factors; Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Cohort Studies; Coronary Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Revascularization; Pyrroles; Risk Assessment; Stroke	2009
Ischemic stroke: a cardiovascular risk equivalent? Lessons learned from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. The Canadian journal of cardiology, 2008, Volume: 24, Issue:9 Topics: Atorvastatin; Cardiovascular Diseases; Cerebral Hemorrhage; Cholesterol; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Pyrroles; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke	2008
Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke, 2008, Volume: 39, Issue:12 Topics: Aged; Atorvastatin; Brain Ischemia; Carotid Stenosis; Cerebral Hemorrhage; Cholesterol, LDL; Coronary Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Ischemic Attack, Transient; Male; Middle Aged; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk; Treatment Outcome	2008
[Vascular prevention after cerebral infarct or transient ischemic accident. Recommendations. March, 2008]. Revue neurologique, 2008, Volume: 164 Spec No 3 Topics: Anticholesteremic Agents; Atorvastatin; Brain; Cerebral Infarction; Cerebrovascular Circulation; Coronary Disease; Heptanoic Acids; Humans; Hypertension; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Pyrroles; Risk Factors; Time Factors	2008
[Statins and stroke]. Medicina clinica, 2008, Oct-25, Volume: 131, Issue:14 Topics: Anticholesteremic Agents; Atorvastatin; Heptanoic Acids; Humans; Ischemic Attack, Transient; Neovascularization, Physiologic; Pyrroles; Stroke	2008
Economic evaluation of atorvastatin for prevention of recurrent stroke based on the SPARCL trial. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2009, Volume: 12, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Atorvastatin; Computer Simulation; Cost-Benefit Analysis; Databases, Factual; Female; Health Services; Heptanoic Acids; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pyrroles; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Saskatchewan; Secondary Prevention; Stroke; Survival Analysis; United States; Young Adult	2009
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology, 2009, Jul-21, Volume: 73, Issue:3 Topics: Age Distribution; Age Factors; Aged; Anticholesteremic Agents; Atorvastatin; Carotid Stenosis; Clinical Trials as Topic; Comorbidity; Coronary Artery Disease; Heptanoic Acids; Humans; Ischemic Attack, Transient; Outcome Assessment, Health Care; Pyrroles; Stroke; Treatment Outcome	2009
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology, 2009, Jul-21, Volume: 73, Issue:3 Topics: Age Distribution; Age Factors; Aged; Anticholesteremic Agents; Atorvastatin; Cerebral Hemorrhage; Cholesterol, LDL; Clinical Trials as Topic; Heptanoic Acids; Humans; Iatrogenic Disease; Ischemic Attack, Transient; Pyrroles; Risk Assessment; Risk Factors; Stroke	2009
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology, 2009, Sep-08, Volume: 73, Issue:10 Topics: Aged; Aged, 80 and over; Atorvastatin; Female; Heptanoic Acids; Humans; Ischemic Attack, Transient; Male; Pyrroles; Secondary Prevention; Stroke	2009
The results support the use of atorvastatin in elderly patients with recent stroke or TIA. Neurology, 2009, Sep-08, Volume: 73, Issue:10 Topics: Aged; Atorvastatin; Heptanoic Acids; Humans; Ischemic Attack, Transient; Pyrroles; Stroke	2009
The role of transcranial Doppler embolic monitoring in the management of intracranial arterial stenosis. Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2011, Volume: 21, Issue:2 Topics: Angiography, Digital Subtraction; Aspirin; Atorvastatin; Blood Flow Velocity; Cerebral Angiography; Clopidogrel; Constriction, Pathologic; Diagnosis, Differential; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Embolism; Ischemic Attack, Transient; Magnetic Resonance Imaging; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine; Tomography, X-Ray Computed; Ultrasonography, Doppler, Transcranial; Young Adult	2011
Atorvastatin in stroke: a review of SPARCL and subgroup analysis. Vascular health and risk management, 2010, Apr-15, Volume: 6 Topics: Age Factors; Aged; Atorvastatin; Carotid Artery Diseases; Cholesterol, LDL; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Middle Aged; Pyrroles; Randomized Controlled Trials as Topic; Sex Factors; Stroke; Treatment Outcome	2010
High dose atorvastatin after stroke or transient ischaemic attack (SPARCL)--does every stroke patient in Pakistan deserve a statin? JPMA. The Journal of the Pakistan Medical Association, 2010, Volume: 60, Issue:6 Topics: Atorvastatin; Evidence-Based Medicine; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Pakistan; Pyrroles; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome	2010
[Case of branch atheromatous disease presenting capsular warning syndrome]. Rinsho shinkeigaku = Clinical neurology, 2010, Volume: 50, Issue:5 Topics: Anticoagulants; Aspirin; Atherosclerosis; Atorvastatin; Dextrans; Diffusion Magnetic Resonance Imaging; Drug Therapy, Combination; Heptanoic Acids; Humans; Infusions, Intravenous; Ischemic Attack, Transient; Magnetic Resonance Angiography; Male; Middle Aged; Pyrroles; Recurrence; Syndrome; Thrombolytic Therapy; Tissue Plasminogen Activator	2010
[Cost-effectiveness analysis of using high doses of atorvastatin for the secondary stroke prevention in Spain]. Revista de neurologia, 2010, Jul-01, Volume: 51, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Atorvastatin; Cost-Benefit Analysis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Male; Middle Aged; Models, Theoretical; Myocardial Infarction; Placebos; Pyrroles; Risk Factors; Secondary Prevention; Spain; Stroke; Treatment Outcome; Young Adult	2010
TIAs - management in general practice. Australian family physician, 2010, Volume: 39, Issue:11 Topics: Anticoagulants; Antihypertensive Agents; Aspirin; Atorvastatin; Clopidogrel; Dipyridamole; Dopamine Antagonists; General Practitioners; Heptanoic Acids; Humans; Hypolipidemic Agents; Ischemic Attack, Transient; Perindopril; Platelet Aggregation Inhibitors; Primary Health Care; Prochlorperazine; Pyrroles; Ticlopidine; Vasodilator Agents; Warfarin	2010
[After TIA and stroke: a statin for secondary prevention?]. MMW Fortschritte der Medizin, 2006, Jun-15, Volume: 148, Issue:24 Topics: Anticholesteremic Agents; Atorvastatin; Clinical Trials as Topic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Placebos; Pyrroles; Recurrence; Stroke; Time Factors	2006
Stroke--an equal opportunity for the initiation of statin therapy. The New England journal of medicine, 2006, Aug-10, Volume: 355, Issue:6 Topics: Atorvastatin; Cholesterol; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Pyrroles; Secondary Prevention; Stroke	2006
Atorvastatin for stroke prevention. The Medical letter on drugs and therapeutics, 2006, Sep-11, Volume: 48, Issue:1243 Topics: Atorvastatin; Cerebral Hemorrhage, Traumatic; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Muscular Diseases; Pyrimidines; Pyrroles; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Stroke; Sulfonamides; Time Factors	2006
Statin therapy after stroke or transient ischemic attack. The New England journal of medicine, 2006, Nov-30, Volume: 355, Issue:22 Topics: Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Pyrroles; Secondary Prevention; Severity of Illness Index; Stroke	2006
[Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure]. Nederlands tijdschrift voor geneeskunde, 2007, Mar-03, Volume: 151, Issue:9 Topics: Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Cholesterol; Heptanoic Acids; Humans; Ischemic Attack, Transient; Pyrroles; Recurrence; Risk Factors; Stroke	2007
[The 2006 American Heart Association selection of the "top ten advances in heart disease and stroke research"]. Revue medicale de Liege, 2007, Volume: 62, Issue:4 Topics: Abnormalities, Drug-Induced; Adolescent; Adult; American Heart Association; Anti-Inflammatory Agents; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Brain Ischemia; Child; Coronary Disease; Heart Diseases; Heart Valve Prosthesis; Heart-Assist Devices; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Obesity; Peptidyl-Dipeptidase A; Process Assessment, Health Care; Pyrroles; Stroke; Tissue Engineering; United States	2007
High-dose atorvastatin after stroke or transient ischemic attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. Journal of the cardiometabolic syndrome, 2008,Winter, Volume: 3, Issue:1 Topics: Adult; Atorvastatin; Cardiovascular Diseases; Cerebral Hemorrhage; Cerebral Infarction; Cholesterol, LDL; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Male; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk; Stroke	2008